SGO 2021 - Dr. David O'Malley Presents on RaPiDS Trial Design - Agenus Inc.

SGO 2021 - Dr. David O'Malley Presents on RaPiDS Trial Design

March 19, 2021 at 9:00 AM CDT to March 25, 2021 at 8:00 PM CDT

RaPiDS (GOG-3028): A Randomized Phase II Study of Balstilimab (AGEN2034) as Monotherapy or in Combination with Zalifrelimab (AGEN1884) in Second-Line Cervical Cancer